Research & Development



  每一個格子里都放一條身體肥胖的大蠶,這些蠶已經不吃東西了,放進繭山之後開始胡亂動彈。   霍去病的眉頭擰成了一疙瘩張嘴就道︰“我們兄弟三個,各個勇猛,董君能承受得起?”时时彩平台—欢迎您!   張湯就是一個依靠俸祿生活的人。360彩票中奖新闻   雲瑯見霍去病跟李敢齊齊的看著自己,就笑道︰“仁義禮智信就是儒,也是儒家的五種道術。這五種美好的品性是儒家希望人能夠具備的五種美德,身懷這五種美德而不顯露的人被他們稱之為君子。儒家的終極目的就是要把天下的每一個漢人都改造成君子,一旦成功,天下就會出現道不過三代,法不二後王這樣有秩序的場面。”   霍去病拍拍李敢的肩膀道︰“反正我是準備好了,一旦立下軍功,就跟陛下要上林苑的園子,就在雲家莊子南邊,你如果冬天來雲家莊子,嘖嘖,那時候,這里就他娘的是神仙地!”360彩票技巧   雲瑯的語氣逐漸有些不耐煩。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo